SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending downwards as investors react to earnings results and future outlook, with concerns focused on debt and increased spending related to AI infrastructure. The community is debating whether the company's AI investments will translate to profits, with some expressing skepticism about the current valuation. Others believe the selloff is an overreaction and a buying opportunity, pointing to Oracle's backlog and potential for long-term growth.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending downwards as the community discusses its potential acquisition of Warner Bros. Discovery and the impact of increased debt. Some traders believe the stock is oversold and poised for a bounce, while others anticipate further declines depending on the outcome of the bidding war with Paramount and potential regulatory hurdles.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

MSFT is trending amid mixed sentiment, with some traders expressing frustration over its recent performance relative to the broader market and other tech stocks; many believe the stock is being manipulated. Despite the negative sentiment, there's optimism regarding Microsoft's AI initiatives and potential upside, with analysts reiterating buy ratings and high price targets.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending as traders discuss its bullish chart structure and potential breakout, fueled by strong buying momentum. Community members are highlighting confidence in the stock's trend and anticipating further upward movement. Some traders point to the company's need for cash and recent news including an acquisition that could affect the company.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

Mawson Infrastructure Group ($MIGI) is trending due to sector-wide strength in Bitcoin mining stocks and speculation around its expanding digital infrastructure, including AI/GPU hosting. The community is discussing the stock's low float, potential for a short squeeze, and anticipation of catalysts from an upcoming Emerging Growth Conference. Some traders are setting aggressive price targets, citing the company's infrastructure buildout and potential for new contracts.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana's stock is trending amid discussions about its upcoming inclusion in the S&P 500, with some traders anticipating a continued rise while others foresee a sell-the-news event. Community members are debating the company's valuation, debt, and potential risks, with a segment highlighting possible fraud and regulatory concerns. Bullish sentiment is fueled by the S&P 500 inclusion, while bears point to the high P/E ratio and subprime loan book.

Beasley Broadcast Group, Inc. is multi-platform media company, which engages in the operation of radio stations in the United States. The firm offers marketing solutions across event platforms. It operates through the following business segments: Audio, Digital, and Other. The company was founded by George G. Beasley in 1961 and is headquartered in Naples, FL.

Beasley Broadcast Group Inc - Ordinary Shares - Class A

BBGI is trending due to its high volatility and potential for sharp scalps, though a confirmed catalyst remains unclear. Community discussions revolve around whether it can repeat the massive gains seen earlier in the day, or if it is set to fade, drawing comparisons to similar volatile runners like $SMX. Traders are actively debating strategies around potential overnight moves and short positions.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares ETF ($GLD) is trending amid discussions of monetary policy and its potential impact on precious metals. Community members are debating whether gold can sustain its rally, while others point to central bank buying and macro uncertainty as continued tailwinds. There's also some discussion about the relationship between gold and silver ($SLV) performance.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices surge to new highs, driven by a potential supply squeeze and strong industrial demand, with retail investors closely monitoring the Gold/Silver ratio. The community is actively discussing potential price targets, the impact of upcoming Fed decisions, and whether the current momentum is sustainable. Some investors express concerns that the metal is overbought, while others point to long-term bullish factors, including potential legal tender status and growing industrial applications.

Biodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Biodexa Pharmaceuticals Plc - ADR

Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals is trending due to increased momentum in low-float biotech stocks, with traders actively discussing its potential for a significant price surge. The community is also highlighting the company's phase 3 trial and analyzing the stock's chart patterns, while noting the company's small market cap relative to the potential market for its lead drug candidate.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

UBS says this sector remains a high-quality, defensive investment theme

Investing.com -- UBS continues to view the medical devices sector as a high-quality, defensive investment theme, supported by long-term demographic shifts and rising global demand.

Sector ETFs Likely to Gain on May Inflation Data

Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick

Investing.com -- Citi analysts revised their MedTech coverage following a volatile first quarter, with several rating changes and adjustments to target prices.

What Are Wall Street Analysts’ Target Price for Medtronic Stock?

While Medtronic has underperformed relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Are Wall Street Analysts Predicting Boston Scientific Stock Will Climb or Sink?

Boston Scientific has outpaced the broader market over the past year and analysts are highly upbeat about its future prospects.

U.S.-China tariff de-escalation is positive for this stock: analyst

Investing.com -- Bank of America analysts say GE HealthCare (NASDAQ:GEHC) should benefit from signs of softening in the U.S.-China trade war, arguing that the worst of the tariff-related pressure may already be priced into the stock.

HSBC shuffles MedTech stocks, cutting 4, upgrading 2

Investing.com -- HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading   Siemens  Healthineers AG  (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting  Align Technology  (NASDAQ:ALGN), Eurofins Scientific SE (EPA:EUFI), IQVIA, and Smith&Nephew (LON:SN) to Hold.

A Neuralink rival backed by&nbsp;a former collaborator of Elon Musk has just received FDA clearance for its brain implant. Precision Neuroscience, a fast-growing startup developing brain-computer interface (BCI) technology,&nbsp;announced on Thursday that it has received clearance from the U.S. Food and Drug Administration to market a&nbsp;key component of its implant system for clinical use.&nbsp;The approval signals&nbsp;an increase in competition in the neurotech space, where Elon Musk’s Neuralink has drawn significant public and regulatory attention.The device, known as the Layer 7 Cortical Interface, is a thin, flexible microelectrode array designed to record and stimulate neural activity without penetrating brain tissue.&nbsp;The FDA has cleared it for clinical use in procedures lasting up to 30 days, allowing surgeons to temporarily implant the array to map brain activity.&nbsp;While not the company’s end-use goal, the clearance enables Precision to generate near-term revenue and gather valuable real-world data.Brain-computer interfaces, or BCIs, are designed to translate neural signals into digital commands to power external devices.&nbsp;Precision’s initial focus is on patients with severe paralysis, helping to restore lost functions such as movement and speech.&nbsp;“Neural decoding algorithms, like all AI-driven products, rely on vast amounts of data,” said Rapoport, Precision’s Chief Science Officer. “This regulatory clearance will exponentially increase our access to high-quality data, which will help us build BCI systems that work more effectively.”The Layer 7 device contains 1,024 electrodes packed onto a film thinner than a human hair. It conforms to the brain’s surface, avoiding the need to pierce neural tissue, unlike traditional deep brain stimulation systems used by companies such as Medtronic.The FDA’s decision places Precision in closer competition with Neuralink, which is currently conducting human trials for its implantable device. Other players in the space include Synchron, backed by Amazon’s (AMZN) Jeff Bezos and Microsoft’s (MSFT) Bill Gates.The approval comes at a time when the broader AI and medical device stocks face pressure.The&nbsp;<a href="https://stocktwits.com/symbol/BOTZ">Global X Robotics &amp; Artificial Intelligence ETF</a> (BOTZ), which tracks companies involved in automation and AI, has fallen 17% this year, while the&nbsp;<a href="https://stocktwits.com/symbol/IHI">iShares U.S. Medical Devices ETF</a> (IHI) is down 2.5% amid President Donald Trump’s&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-orders-tariff-probe-on-critical-minerals-escalating-us-china-trade-war-tensions/chQPV2TRbOY">sweeping</a> tariffs, global policy&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/imf-chief-warns-trade-policy-uncertainty-off-the-charts-global-growth-forecast-cut/chQEvFYRbfY">uncertainty</a>, and tighter regulatory scrutiny.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/lockheed-martin-stock-drops-after-cfo-jay-malave-steps-down-just-days-before-q1-earnings/chQEM9RRbfN">Lockheed Martin Stock Drops After CFO Jay Malave Steps Down Just Days Before Q1 Earnings</a>

Neuralink, Tesla, and SpaceX founder Elon Musk departs the U.S. Capitol Building on March 5, 2025 in Washington, DC. (Photo by Andrew Harnik/Getty Images)

Elon Musk’s Neuralink Faces New FDA-Approved Rival In Precision Neuroscience

The device, known as the Layer 7 Cortical Interface, is a thin, flexible microelectrode array designed to record and stimulate neural activity without penetrating brain tissue. 

Equity

BlackRock Institutional Trust Company N.A. - iShares U.S. Medical Devices ETF

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

IHI
iShares US Medical Devices ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest IHI News

IHIiShares US Medical Devices ETF